Repository

Publications

Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic

Zanuso V, Nash T, Casolino R, Armstrong G, Pallise O, Milne J, Braconi C.
BMC Cancer . 2024 May 16;24(1):597. doi: 10.1186/s12885-024-12279-6
2024 
Result from  

The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland.

Krupa L, Kalinowski P, Ligocka J, Dauer M, Jankowski K, Gozdowska J, Kruk B, Milkiewicz P, Zieniewicz K, Krawczyk M, Weber SN, Lammert F, Krawczyk M.
Eur J Clin Invest . 2024 Aug;54(8):e14213. doi: 10.1111/eci.14213
2024 
Result from  

The morphomolecular features of cholangiocarcinoma in the personalised era.

Field D, Carpino G, Doukas M, Kendall TJ.
Diagnostic Histopathology . 2024 Apr 4;30(4). doi: 10.1016/j.mpdhp.2024.01.004.
2024 
Result from  

Recommendations maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.

Kendall T, Overi D, Guido M, Braconi C, Banales J, Cardinale V, Gaudio E, Koerkamp BG, Carpino G.
JHEP Rep . 2024 Mar 12;6(6):101067. doi: 10.1016/j.jhepr.2024.101067
2024 
Result from  
OA Funded by  

Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.

Ortiz-Rivero S, Peleteiro-Vigil A, Abete L, Lozano E, Hammer HS, Giacomo SD, Abad M, Boix L, Forner A, Reig M, Macias RIR, Pötz O, Marin JJG, Briz O.
Biomed Pharmacother . 2024 Jan:170:116038. doi: 10.1016/j.biopha.2023.116038
2024 
Result from  
Join the Action
JOIN